CXCR1/IL-8RA Antibody Blocking Peptide
Novus Biologicals, part of Bio-Techne | Catalog # NB600-1142PEP
Key Product Details
Conjugate
Applications
Product Specifications
Description
Application Notes
Specificity
Protein / Peptide Type
Formulation, Preparation and Storage
NB600-1142PEP
| Formulation | Peptide dissolved in dH20. Contains no BSA. |
| Preservative | No Preservative |
| Concentration | 1 mg/ml |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Store at -80C. Avoid freeze-thaw cycles. |
Background: CXCR1/IL-8RA
CXCR1, also known as IL-8RA and CD181, is an approximately 60 kDa 7TM glycoprotein that functions as a receptor for the chemokine CXCL8/IL-8. It is expressed on neutrophils, monocytes, CD8 T cells, FoxP3+ CD4 Treg cells, mast cells, neuronal and glial cells, vascular endothelial cells, and melanoma. CXCR1 forms homodimers and heterodimers with CXCR2/IL-8RB. It can be cleaved from neutrophils in the lungs of cystic fibrosis patients to release fragments that promote CXCL8 production from airway epithelial cells. CXCR1 mediates neutrophil activation and chemotaxis to sites of inflammation as well as angiogenesis and melanoma invasiveness.
Long Name
Alternate Names
Gene Symbol
Additional CXCR1/IL-8RA Products
Product Documents for CXCR1/IL-8RA Antibody Blocking Peptide
Product Specific Notices for CXCR1/IL-8RA Antibody Blocking Peptide
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.